Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Reshape Lifesciences Inc (NQ: RSLS )

0.1670 +0.0010 (+0.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 201,123
Open 0.1700
Bid (Size) 0.1650 (262)
Ask (Size) 0.1700 (1)
Prev. Close 0.1660
Today's Range 0.1601 - 0.1710
52wk Range 0.1414 - 2.670
Shares Outstanding 6,166,554
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
Patent Significantly Strengthens Intellectual Property Portfolio 
From ReShape Lifesciences Inc
Via GlobeNewswire

Performance

YTD
-37.41%
-37.41%
1 Month
+2.71%
+2.71%
3 Month
-20.17%
-20.17%
6 Month
-35.10%
-35.10%
1 Year
-92.89%
-92.89%

More News

Read More
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
From ReShape Lifesciences Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
From ReShape Lifesciences Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why ReShape Lifesciences Stock Is Ripping Higher
Via Benzinga
Exposures Product Safety
Why Is Shattuck Labs (STTK) Stock Up 93% Today?
Via InvestorPlace
RBLX Stock Alert: Wells Fargo Initiates Roblox Coverage With ‘Overweight’ Rating
Via InvestorPlace
PLTR Stock: Palantir Renews UniCredit Partnership
Via InvestorPlace
Why Is ReShape Lifesciences (RSLS) Stock Up 68% Today?
Via InvestorPlace
Exposures Product Safety
US Stocks Mixed; Producer Prices Unchanged For November
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exposures Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
ABM Industries, Adobe And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Why ReShape Lifesciences Jumped After-Hours
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
From ReShape Lifesciences Inc
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.